BofA Securities Adjusts Price Target on TG Therapeutics to $10 From $9, Maintains Underperform Rating

MT Newswires00:30 · Ratings

Express News | TG Therapeutics Inc : BofA Global Research Raises Price Objective to $10 From $9

BreakingsJan 7 21:33

Jefferies Sticks to Their Buy Rating for TG Therapeutics (TGTX)

TipRanksJan 5 17:45 · Ratings

Investors in TG Therapeutics (NASDAQ:TGTX) Have Seen Splendid Returns of 185% Over the Past Five Years

Simply Wall StDec 31, 2024 18:33

Will TG Therapeutics, Inc. (TGTX) Make You Rich In 2025?

Yahoo FinanceDec 25, 2024 11:58

Unusual Options Activity: XP, CRS and Others Attract Market Bets, XP V/OI Ratio Reaches 384.6

EST Dec 10th Afternoon Delivery - In the last two hours of trading, 8 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options

Futu NewsDec 11, 2024 02:30